卡塔尔哈马德医疗公司与AbbVie合作, 为临床研究人员启动CRISP培训方案。 Qatar’s Hamad Medical Corp partners with AbbVie to launch CRISP training program for clinical research staff.

卡塔尔的哈马德医疗公司与AbbVie生物制药业海湾销售商合作,启动了CRISP方案,这是与临床研究专业人员协会共同制定的全球临床研究培训倡议。 Hamad Medical Corporation in Qatar has partnered with AbbVie Biopharmaceuticals Gulf Levant to launch the CRISP programme, a global clinical research training initiative developed with the Association of Clinical Research Professionals. 该方案将在临床良好做法、病人安全、道德和协议设计等领域向卫生监测中心工作人员提供全面的培训、认证和持续发展,以提高研究质量,符合国际标准,并支持卡塔尔的医疗创新。 The programme will provide HMC staff with comprehensive training, certifications, and ongoing development in areas like good clinical practice, patient safety, ethics, and protocol design, aiming to improve research quality, align with international standards, and support medical innovation in Qatar.